Compare Crowdstrike Holdings Inc (CRWD) vs CVS Health Corp (CVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crowdstrike Holdings Inc vs CVS Health Corp — how do they compare? Crowdstrike Holdings Inc trades at $267.07 (market cap $269.31B), while CVS Health Corp trades at $85.76 (market cap $112.29B). The key difference: Crowdstrike Holdings Inc is far larger — about 2.4× CVS Health Corp's market cap, and CVS Health Corp pays a 3.03% dividend while Crowdstrike Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and CVS Health Corp for 83 Days on average.
| CRWD | CVS | |
|---|---|---|
Market Cap | $269.31B | $112.29B |
Volume | 9,381,560 | 7,763,676 |
Sector | Technology | Health |
52-Week High | $278.86 | $110.60 |
52-Week Low | $87.56 | $70.08 |
Typical Hold Time | 97 Days | 83 Days |
Enterprise Value | $265.11B | $174.64B |
Dividend Yield | — | 3.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CrowdStrike (CRWD) trades at $265.44, down 4.81% on the day but remains near its 52-week high. The stock shows strong technical momentum with a bullish moving average signal and has consistently beaten earnings expectations in recent quarters. Revenue growth remains robust at $3.95 billion for 2025, though profitability metrics show mixed results with a net income margin of -0.49%. Analyst sentiment remains overwhelmingly positive with 76% buy ratings and a consensus price target of $235.74.
CrowdStrike presents a compelling growth story with strong revenue expansion and market leadership in cybersecurity, though elevated valuation multiples and recent profitability challenges warrant caution. The company benefits from AI-driven cybersecurity demand but faces execution risks and competitive pressures. Current levels offer potential for long-term investors comfortable with growth stock volatility.
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →
